Table 3.
Advantages and disadvantages of current technologies in biomarker discovery
| Biomarker | Detection Technology | Advantages | Disadvantages |
|---|---|---|---|
| Proteins and peptides | Mass spectrometry | High specificity, accurate identification of proteins | Requires significant optimization, time-consuming, limited dynamic range of detection, affected by abundant proteins |
| Affinity-based multiplex assays | High throughput, allows absolute quantification, requires small sample amounts, does not require depletion of abundant proteins | Detection limited to selected protein targets, potential cross reactivity of antibodies or aptamers may contribute to false positives | |
| ctDNA | Digital PCR | Cost effective, high accuracy and reproducibility | Lacks standardization and is limited to 1–2 mutations per test |
| BEAMing | High sensitivity, accuracy, and reproducibility | Lacks standardization and is limited to a single mutation per test | |
| Next generation sequencing | Allows large-scale coverage | Costly and complex, low sensitivity | |
| miRNA and lncRNA | Quantitative PCR | Widely used, straightforward, and cost effective | Requires a standard curve and specificity is dependent on primer design |
| Exosomes | ExoScreen | High throughput, requires small sample amounts, and eliminates complicated isolation steps | Lacks normalization and standardization |
| Circulating tumor cells | Cell Search | Highly specific and robust, and has minimal variability | Requires known cell surface marker (i.e. EpCAM) to capture cells |
| Slated spiral microfluidics | Fast processing time and cost effective | Requires large sample volume | |
| Circulating immune cells | Flow cytometry | High throughput, able to screen multiple markers simultaneously | Limited number of markers due to spectral overlap |
| Mass cytometry | High throughput, able to screen multiple markers simultaneously | Requires significant expertise, slow acquisition rate and requires more stringent sample preparation |